Separation Design Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Separation design group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Separation Design Group Today - Breaking & Trending Today

Investegate |Belluscura PLC Announcements | Belluscura PLC: Belluscura Expands its Patent Portfolio

Investegate announcements from Belluscura PLC, Belluscura Expands its Patent Portfolio ....

United Kingdom , City Of , Robert Rauker , Paul Mcmanus Sam Allen , Anthony Dyer , Neil Baldwin , Walbrook Pr Ltd Media Investor Relations , Advisory Partners Limited , Separation Design Group , Replaceable Molecular Sieve Technology , Continuous Positive Airway Pressure , Dowgate Capital Limited Broker , Oxygen Enrichment Patent , New Patents Issue , Replaceable Molecular Sieve , Separation Design , Chief Executive , Chief Financial , Partners Limited , Capital Limited , Investor Relations , Investegate Announcements , Investegate Company Announcements , Belluscura Plc , Egulatory News Service , Egulatory News Service And Regulatory ,

Investegate |Belluscura PLC Announcements | Belluscura PLC: Intention to Float

Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus / Sam Allen

About Belluscura plc
(
www.belluscura.com
)
Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations.

Background & history
Belluscura was established in the UK in December 2015 with the object of commercialising intellectual property in the medical device space. The Company is currently focused on devices and treatments involving enriched oxygen.

The Company has raised approximately $11.7 million since 2018 in a number of fundraising rounds in order to develop and commercialise the Company s product portfolio. ....

United States , United Kingdom , City Of , Robert Rauker , Paul Mcmanus Sam Allen , Anthony Dyer , Neil Baldwin , Dowgate Capital Ltd Broker Bookrunner , Walbrook Pr Ltd Media Investor Relations , London Stock Exchange , Separation Design Group , London Stock Exchange Admission , Research Development , World Health Organisation , International Regulatory , Us Food Drug Administration , Sales Customer Service , Advisory Partners Ltd , Chronic Obstructive Pulmonary Disease , Nominated Adviser , Dowgate Capital , Customer Service , Regulatory Executive , Device Compliance , Admission Document , Chief Executive ,

Investegate |Tekcapital plc Announcements | Tekcapital plc: Belluscura FDA Clearance

Portfolio Company Update
Belluscura plc announced the receipt of 510(k) Clearance from the US Food and Drug Administration (the FDA ) for its X-PLO
2R™, Portable Oxygen Concentrator

Tekcapital plc, (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products from investing in university technology, announces that its portfolio company Belluscura plc has been granted 510(k) clearance and marketing authorisation by the U.S. Food and Drug Administration (FDA) for the X-PLO
2R POC portable oxygen concentrator (POC). Belluscura developed the X-PLO
2R POC with their research partner, Separation Design Group, an award-winning oxygen enrichment research laboratory. ....

United Kingdom , City Of , Robert Rauker , Abigail Wayne Rob Rees , Cliffordm Gross , Richard Morrison Charlie Bouverat , London Stock Exchange , Separation Design Group , Regulatory Information Service , Drug Administration , Market Of The London Stock Exchange , Investor Communications , Tekcapital Plc , Sp Angel Corporate Finance , Portfolio Company , Market Abuse Regulations , Portable Oxygen , Chronic Obstructive Pulmonary Disease , Global Market Insights , Enterprise Investment Scheme , Executive Chairman , Nominated Adviser , Charlie Bouverat , Corporate Finance , Rob Rees , Corporate Broking ,